Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00622102 · ClinicalTrials.gov registry record · NA
Testing Strategies to Improving Warfarin Adherence
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT00622102: Completed NA study, sponsored by University of Pennsylvania.
NCT00622102 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00622102, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
We are performing a research study to learn more about the control of an individual's blood thinning (anticoagulation) on warfarin. Individuals from an anticoagulation clinic are being asked to participate in order to see if a lottery which provides the opportunity to win money in combination with the use of the Med-eMonitor might be useful in helping patients to achieve better control of their anticoagulation therapy. Half of the participants will be enrolled in the lottery arm and the other half will be a control group who will receive the Med-eMonitor only.
Interventions
- BEHAVIORAL Lottery arm (Lottery and Med-eMonitor)
- BEHAVIORAL Non-Lottery (Med-eMonitor only)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00622102
The ClinicalTrials.gov registry entry for NCT00622102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lottery arm (Lottery and Med-eMonitor) is the first listed.
NCT00622102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00622102 about?
NCT00622102 is a clinical study titled "Testing Strategies to Improving Warfarin Adherence". We are performing a research study to learn more about the control of an individual's blood thinning (anticoagulation) on warfarin. Individuals from an anticoagulation clinic are being asked to participate in order to see if a lottery which provides the opportunity to win money in combination with t...
What is the current status of trial NCT00622102?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2007-12. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00622102?
The interventions under investigation include: Lottery arm (Lottery and Med-eMonitor) (BEHAVIORAL), Non-Lottery (Med-eMonitor only) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00622102?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.